Ron Bentsur
Affiliations
- Chairman & Ceo at Nuvectis Pharma Inc. (NVCT), 2025-01-03
- Director at Beyond Air Inc. (XAIR), 2024-11-27
- Director at Stemline Therapeutics Inc (STML), 2020-06-10
- Chief Executive Officer at Urogen Pharma Ltd. (URGN), 2019-01-10
- Chief Executive Officer at Keryx Biopharmaceuticals Inc (KERX), 2015-04-09
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NVCT | $4.65 | 4,500 | $20,925.00 | 3,270,924 | 2024-12-24 | Filing |
| NVCT | $4.92 | 20,000 | $98,400.00 | 3,266,424 | 2024-11-15 | Filing |
| NVCT | $6.74 | 1,940 | $13,075.60 | 3,246,424 | 2024-05-14 | Filing |
| NVCT | $6.40 | 2,000 | $12,800.00 | 3,244,484 | 2024-05-10 | Filing |
| NVCT | $10.29 | 5,000 | $51,450.00 | 3,242,484 | 2024-03-18 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| XAIR | $6.53 | 40,000 | $261,104.00 | 142,436 | 2022-06-30 | Filing |
| XAIR | $13.99 | 6,464 | $90,431.36 | 182,436 | 2021-11-24 | Filing |
| XAIR | $13.44 | 31,000 | $416,640.00 | 188,900 | 2021-11-24 | Filing |
| XAIR | $6.36 | 23,419 | $148,944.84 | 182,436 | 2021-02-12 | Filing |
| XAIR | $6.28 | 1,500 | $9,420.00 | 182,436 | 2021-02-11 | Filing |